Can Low-Intensity Extracorporeal Shockwave Therapy Improve Erectile Function?

Can Low-Intensity Extracorporeal Shockwave Therapy Improve Erectile Function?

A 6-Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction. By: Yoram Vardi *, Boaz Appel, Giris Jacob, Omar Massarwi, Ilan Gruenwald In the past decade, phosphodiesterase 5 inhibitors (PDE5-Is) have become available for the treatment of erectile dysfunction (ED). However, their effect is still limited to the sexual act and probably do not improve spontaneous erections. These limitations are probably due to their inability to improve penile blood flow for a time period that is sufficient to allow optimal oxygenation and recovery of cavernosal vasculature. Recently, the effect of long-term daily use of PDE5-Is on endothelial function (EnF) has been shown to induce a short-term improvement in erectile function (EF) but probably not a longstanding one [1–3]. Read…

read more
Low-Intensity Extracorporeal Shock Wave Therapy

Low-Intensity Extracorporeal Shock Wave Therapy

A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor Therapy. BY: Ilan Gruenwald, MD, Boaz Appel, MD, and Yoram Vardi, MD Neuro-urology Unit, Rambam Healthcare Campus, Haifa, Israel Erectile dysfunction (ED) is one of the most common disorders of middle-aged men that profoundly affect their quality of life [1]. Although tremendous advances for treating this disorder have been made in the past decade, most currently available treatment modalities still rely on an “on demand” regime, of which up to 35% are unsuccessful [2–4]. From our experience, ED patients who were treated with a phosphodiesterase type 5 inhibitor (PDE5i) tend to search for an alternative treatment modality that would ameliorate their ED. Hence,…

read more